Live feed17:35:04·49dINSIDERFilingvia QuantisnowChief Executive Officer Kulkarni Samarth converted options into 19,250 shares and sold $517,334 worth of shares (9,798 units at $52.80), increasing direct ownership by 4% to 235,558 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.CRSP· CRISPR Therapeutics AGHealth CareOriginal source